May 20, 2022Kidney MedicineOpen Access

Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Key points are not available for this paper at this time.

East et al. (2022) studied this question.

View Full Paper

Ask AI

Bookmark